Circulating tumor cells (CTCs) have been utilized in the diagnosis and prognosis of tumor. However, the CTC concentration is extremely low to be detected in peripheral blood. Many existing methods suffer from either expensive labeling or complex operation. In this study, we constructed a label-and enzyme-free and sensitive method to detect the breast cancer CTCs. First of all, a probe containing a breast cancer cell-specific aptamer and a complementary single-stranded DNA (trigger DNA P1) were designed. When the target cells are present, the aptamer binds to the CTCs and releases P1 which triggers the strand displacement amplification. This process generates three-way junction structure DNA, the specific translocation signals of which are identified by nanopore assay. The detection limit of tumor cells is 5 in the current experimental setup and can be further reduced. Furthermore, the method is demonstrated in a clinical sample test with high recovery rate and accuracy. Our results suggest that this method could be applied to early diagnosis of metastatic recurrence and prognosis determination.
Nanoscale transport through nanopores and live-cell membranes plays a vital role in both key biological processes as well as biosensing and DNA sequencing. Active translocation of DNA through these nanopores usually needs enzyme assistance. Here we present a nanopore derived from truncated helicase E1 of bovine papillomavirus (BPV) with a lumen diameter of c.a. 1.3 nm. Cryogenic electron microscopy (cryo-EM) imaging and single channel recording confirm its insertion into planar lipid bilayer (BLM). The helicase nanopore in BLM allows the passive single-stranded DNA (ssDNA) transport and retains the helicase activity in vitro. Furthermore, we incorporate this helicase nanopore into the live cell membrane of HEK293T cells, and monitor the ssDNA delivery into the cell real-time at single molecule level. This type of nanopore is expected to provide an interesting tool to study the biophysics of biomotors in vitro, with potential applications in biosensing, drug delivery and real-time single cell analysis.
Interface between neuron cells and biomaterials is the key to real-time sensing, transmitting and manipulating of neuron activities, which are the long-term pursue of scientists and gain intense research focus recently. It is of great interest to develop a sensor with exquisite sensitivity and excellent selectivity for real-time monitoring neurotransmitters transport through single live cell. Sensing techniques including electrode-based methods, optogenetics, and nanowire cell penetration systems have been developed to monitor the neuron activities. However, their biocompatibilities remain a challenge. Protein nanopores with membrane compatibility and lumen tunability provide real-time, single-molecule sensitivities for biosensing of DNA, RNA, peptides and small molecules. In this study, an engineered protein nanopore MspA (Mycobacterium smegmatis porin A) through site-directed mutation with histidine selectively bind with Cu2+ in its internal lumen. Chelation of neurotransmitters such as L-glutamate (L-Glu), dopamine (DA) and norepinephrine (NE) with the Cu2+ creates specific current signals, showing different transient current blockade and dwell time in single channel electrophysiological recording. Furthermore, the functionalized M2MspA-N91H nanopores have been embedded in live HEK293T cell membrane for real-time, in situ monitoring of extracellular L-glutamate translocating through the nanopore. This biomimetic neurotransmitter nanopore has provided a new platform for future development of neuron sensors, drug carrier and artificial synapse.
Here, we constructed a dual-fluorescence method for detection of pyrophosphatase (PPase) using pyrophosphate-cerium coordination polymeric nanoparticles (PPi-Ce CPNs) and cadmium telluride quantum dots (CdTe QDs) as signal molecules. The dual...
Modeling of the variogram is a critical step for most geostatistical methods. However, most of the prevalent variogram-based solutions are designed without sufficient consideration of the effect of the interpolation process on their application. This paper proposes an automated variogram modeling framework, which simultaneously considers the fit of the experimental variogram and interpolation accuracy in the modeling variogram interpolation result. The variogram modeling framework can be treated as a nonlinear optimization problem with two sub-goals. The first is to optimize the goodness of fit between the experimental and theoretical variogram values under the conditions of their designated parameters. Second, we seek to optimize the difference between measured values and the associated kriging estimates with the candidate variogram model. A typical case study was chosen using a public dataset to test the proposed method, which was implemented using a genetic algorithm, and its performance was compared with the ones of other commonly applied variogram modeling approaches. As expected, the traditional variogram modeling method that only considers fitting standard experimental variograms showed severe sensitivity to errors in data and parameters; classical cross-validation modeling results tended to overlook the experimental variograms. By contrast, the proposed method succeeded in producing variogram models with robust, high-quality kriging estimates and favorable fitness of experimental variograms in a more powerful and flexible way.
Nanopores are label-free single-molecule analytical tools
that
show great potential for stochastic sensing of proteins. Here, we
described a ClyA nanopore functionalized with different nanobodies
through a 5–6 nm DNA linker at its periphery. Ty1, 2Rs15d,
2Rb17c, and nb22 nanobodies were employed to specifically recognize
the large protein SARS-CoV-2 Spike, a medium-sized HER2 receptor,
and the small protein murine urokinase-type plasminogen activator
(muPA), respectively. The pores modified with Ty1, 2Rs15d, and 2Rb17c
were capable of stochastic sensing of Spike protein and HER2 receptor,
respectively, following a model where unbound nanobodies, facilitated
by a DNA linker, move inside the nanopore and provoke reversible blockade
events, whereas engagement with the large- and medium-sized proteins
outside of the pore leads to a reduced dynamic movement of the nanobodies
and an increased current through the open pore. Exploiting the multivalent
interaction between trimeric Spike protein and multimerized Ty1 nanobodies
enabled the detection of picomolar concentrations of Spike protein.
In comparison, detection of the smaller muPA proteins follows a different
model where muPA, complexing with the nb22, moves into the pore, generating
larger blockage signals. Importantly, the components in blood did
not affect the sensing performance of the nanobody-functionalized
nanopore, which endows the pore with great potential for clinical
detection of protein biomarkers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.